Developer docs
API playgroundTry for free, no card

Search company profiles

Cambrium

Full company profile

uuid0000q5m

Namestring
Cambrium
Legal namestring
Cambrium GmbH
Websiteurl
cambrium.bio
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Cambrium GmbH is a Berlin-based synthetic biology company founded in 2020 that engineers novel enzymes, polymers, and peptides for enterprise customers in materials-intensive industries. The company operates a "molecular intelligence" platform that combines AI-driven prediction of amino acid sequence behavior with synthetic biology manufacturing to produce molecules whose performance characteristics — strength, flexibility, durability, energy return, biodegradability, bioidentity — are engineered in silico before synthesis and are not achievable through conventional petrochemical chemistry. Headcount is in the 11–50 range and the legal entity is Cambrium GmbH (HRB 220753 B), headquartered at Rheinsberger Straße 77A, 10115 Berlin.

The product portfolio spans four verticals. In personal care, the company sells NovaColl™ (a skin-identical vegan collagen peptide), RevaBond™ (bond repair), LumaCell™ (cellular longevity), and EvoSance™ (hair follicle rejuvenation). In apparel and footwear, it offers Microcellular Foam (energy-return midsoles), Protective Coatings, and Stretch Fibres. The home-care line comprises bio-based enzymes for low-temperature washing detergents and surface cleaners. Mobility and luxury fashion are listed as pipeline verticals. The company has historically operated under a sales-led B2B partnership motion ("Partner with us," "Order samples" CTAs), and in January 2025 added a distribution channel through Brenntag Beauty & Personal Care for NovaColl across key European markets.

Revenue mechanics combine direct B2B specialty-ingredient sales with collaborative custom-development engagements for enterprise customers; pricing is not publicly disclosed and the public posture remains sample/pilot-stage. The company is privately held and venture-backed, having raised an €8 million seed round in October 2023 led by Essential Capital, with a seed extension closed in November 2024 led by Gradient Ventures. Leadership is founder-led: Dr. Mitchell Duffy (CEO), Dr. Charlie Cotton (CSO, co-founder), and Dr. Pierre Salvy (CTO), supported by a Head of Polymers, Chief of Staff, and VP of Business Development.

Short descriptiontext

Cambrium is a Berlin-based synthetic biology company that uses an AI-driven molecular intelligence platform to design and manufacture novel enzymes, polymers, and peptides for enterprise customers in personal care, apparel and footwear, and home care industries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
synthetic biology, performance materials, molecular engineering, bio-based ingredients, specialty polymers
Industry3 codes
PRIMARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Specialty Bio-based Ingredients
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Materials Sales
TypeOne Time License
Description

Revenue generated through direct B2B sales of specialty molecular ingredients and performance materials to enterprise customers in target industries. The company manufactures and supplies novel enzymes, polymers, and peptides to partner companies for integration into their products.

cambrium.bio
2Collaborative Development
TypeProfessional Services
Description

Revenue from co-development partnerships with companies seeking custom molecular solutions. Cambrium partners with companies to develop materials that didn't exist until they made them, suggesting custom development and manufacturing agreements.

cambrium.bio
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1NovaColl™
Description

Bioidentical anti-aging peptide for personal care applications

cambrium.bio
+7 more records
Core offering1 text field

Cambrium engineers and manufactures high-performance proteins and specialty molecular ingredients—including enzymes, polymers, and peptides—using a proprietary molecular intelligence platform that combines AI-driven prediction with synthetic biology production. The company sells these bio-based, biodegradable ingredients to enterprise customers in personal care, apparel and footwear, home care, and mobility industries as sustainable alternatives to petrochemical- and animal-derived inputs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Independent studies have shown positive results for NovaColl efficacy
Product overview1 text field

Cambrium is a synthetic biology company that develops sustainable performance molecules using AI-powered molecular intelligence. Their platform spans three molecular systems — enzymes, polymers, and peptides — enabling the design and manufacturing of materials for personal care, apparel and footwear, home care, and other industries. The product portfolio includes NovaColl™ (bioidentical anti-aging peptide), RevaBond™ (bond repair), LumaCell™ (cellular longevity), and EvoSance™ (hair rejuvenation) for personal care; Microcellular Foam, Protective Coatings, and Stretch Fibers for apparel and footwear; and custom enzymes for home care applications. All products are designed for biodegradability and sustainable alternatives to petrochemical and animal-derived ingredients.

Product and service8 records
1NovaColl™
CategoryPersonal Care Ingredient
Description

Bioidentical anti-aging peptide for personal care applications — a skin-identical vegan collagen alternative that mirrors what the body naturally produces, offering deeper absorption and stronger signaling compared to synthetic chemistry alternatives.

2RevaBond™
CategoryPersonal Care Ingredient
Description

All-natural bond repair ingredient for personal care formulations, designed to restore hair or material bonds.

3LumaCell™
CategoryPersonal Care Ingredient
Description

Active ingredient designed for longevity at the cellular level in personal care applications.

4EvoSance™
CategoryPersonal Care Ingredient
Description

Follicle-first hair rejuvenation technology for personal care applications.

5Microcellular Foam
CategoryPerformance Polymer / Footwear Material
Description

Performance polymer engineered for apparel and footwear applications — microcellular foam tuned for energy return in footwear midsoles, providing stretch, resilience, and breathability.

6Protective Coatings
CategoryPerformance Polymer / Coating Material
Description

Invisible protective coating technology for apparel, footwear, and accessories, providing durability and protection without compromising aesthetics.

7Stretch Fibres
CategoryPerformance Polymer / Textile Fiber
Description

Performance fiber technology engineered for stretch and resilience in textile applications, designed to provide comfort and flexibility.

8Enzymes and Bio-based Actives
CategoryHome Care Enzyme Ingredient
Description

Custom enzymes engineered for specific cleaning challenges in home care applications — designed to clean effectively at lower temperatures, biodegrade completely, and work gently on fabrics and surfaces.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-10
Description

Brenntag Beauty and Personal Care partnered with Cambrium to launch skin-identical vegan collagen (NovaColl) in key European markets. Brenntag, as a global chemical distributor, provides Cambrium with access to their extensive personal care customer network across Europe, enabling wide distribution of Cambrium's breakthrough collagen ingredient.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor developing animal-free proteins and peptides via precision fermentation for personal care and food applications. Geltor and Cambrium both use synthetic biology to produce bioidentical collagen and other proteins as sustainable alternatives to animal-derived ingredients, targeting the same CPG brand customers.

TypeDirect peer
Description

Direct competitor using brewed protein (fermentation-based) to produce structural protein fibers for apparel and footwear applications. Spiber and Cambrium's apparel & footwear division both target performance material customers seeking bio-based alternatives to petroleum-derived synthetics like spandex and nylon.

TypeDirect peer
Description

Direct competitor producing lab-grown proteins (including spider silk-inspired fibers and beauty ingredients) via synthetic biology for fashion, beauty, and personal care applications. Bolt Threads and Cambrium both bridge sustainable protein materials from biotech into CPG and apparel end markets.

TypeDirect peer
Description

Direct competitor applying generative AI and machine learning to protein design, helping partners engineer novel proteins faster. Cradle and Cambrium share the same AI-for-biology platform thesis and target similar enterprise customers in the protein engineering space, though Cradle operates more as a software/partner model.

TypeDirect peer
Description

Direct competitor using bio-fabrication and synthetic biology to produce sustainable materials, including bio-based leather alternatives and protein-based materials for fashion and automotive applications. Modern Meadow and Cambrium both target materials-intensive industries with fermentation-derived alternatives to animal- and petrochemical-derived inputs.

TypeEmerging player
Description

Emerging European synthetic biology company producing fermentation-derived specialty ingredients for cosmetics, food, and materials. Insempra overlaps with Cambrium on bio-based personal-care ingredients and shares the European market footprint, though Insempra's ingredient portfolio is more nutrition-oriented.

TypeBroad incumbent
Description

Global specialty ingredients leader with a deep personal-care and beauty portfolio serving the same CPG customers Cambrium targets via Brenntag. Croda's Personal Care division competes directly with NovaColl and other Cambrium bioactive peptides, while its established regulatory dossiers and global sales force represent the benchmark Cambrium must displace.

TypeBroad incumbent
Description

Major specialty chemicals company with significant personal-care, cosmetics, and sustainable materials businesses. Evonik's Care Solutions division and its biolab-produced ingredients (e.g., ceramides, peptides) compete directly with Cambrium's bioactives, while its polymer portfolio overlaps with Cambrium's performance materials work.

TypeBroad incumbent
Description

World's largest chemical company with a Care Chemicals division serving personal care, home care, and industrial cleaning customers — overlapping with Cambrium's enzymatic home-care actives and personal-care peptides. BASF's massive R&D budget and established CPG relationships represent both a competitive threat and a potential partnership/acquisition counterparty for Cambrium.

TypeBroad incumbent
Description

Global leader in nutrition, health, and beauty ingredients formed by the merger of DSM and Firmenich. The Personal Care & Aroma Ingredients division competes directly with Cambrium's peptide and bioactive portfolio for CPG brand customers, while dsm-firmenich's sustainability positioning overlaps with Cambrium's animal-free value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambrium

Specialty Bio-based Ingredientscambrium.bio

Cambrium is a Berlin-based synthetic biology company that uses an AI-driven molecular intelligence platform to design and manufacture novel enzymes, polymers, and peptides for enterprise customers in personal care, apparel and footwear, and home care industries.

What Cambrium does

Cambrium GmbH is a Berlin-based synthetic biology company founded in 2020 that engineers novel enzymes, polymers, and peptides for enterprise customers in materials-intensive industries. The company operates a "molecular intelligence" platform that combines AI-driven prediction of amino acid sequence behavior with synthetic biology manufacturing to produce molecules whose performance characteristics — strength, flexibility, durability, energy return, biodegradability, bioidentity — are engineered in silico before synthesis and are not achievable through conventional petrochemical chemistry. Headcount is in the 11–50 range and the legal entity is Cambrium GmbH (HRB 220753 B), headquartered at Rheinsberger Straße 77A, 10115 Berlin.

The product portfolio spans four verticals. In personal care, the company sells NovaColl™ (a skin-identical vegan collagen peptide), RevaBond™ (bond repair), LumaCell™ (cellular longevity), and EvoSance™ (hair follicle rejuvenation). In apparel and footwear, it offers Microcellular Foam (energy-return midsoles), Protective Coatings, and Stretch Fibres. The home-care line comprises bio-based enzymes for low-temperature washing detergents and surface cleaners. Mobility and luxury fashion are listed as pipeline verticals. The company has historically operated under a sales-led B2B partnership motion ("Partner with us," "Order samples" CTAs), and in January 2025 added a distribution channel through Brenntag Beauty & Personal Care for NovaColl across key European markets.

Revenue mechanics combine direct B2B specialty-ingredient sales with collaborative custom-development engagements for enterprise customers; pricing is not publicly disclosed and the public posture remains sample/pilot-stage. The company is privately held and venture-backed, having raised an €8 million seed round in October 2023 led by Essential Capital, with a seed extension closed in November 2024 led by Gradient Ventures. Leadership is founder-led: Dr. Mitchell Duffy (CEO), Dr. Charlie Cotton (CSO, co-founder), and Dr. Pierre Salvy (CTO), supported by a Head of Polymers, Chief of Staff, and VP of Business Development.

Cambrium firmographics

Firmographics
Name
Cambrium
Legal name
Cambrium GmbH
Website
https://cambrium.bio
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Cambrium is a Berlin-based synthetic biology company that uses an AI-driven molecular intelligence platform to design and manufacture novel enzymes, polymers, and peptides for enterprise customers in personal care, apparel and footwear, and home care industries.
Ownership category
akta.pro rank

Cambrium industry classification

Industry
Product category
Specialty Bio-based Ingredients
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)

Keywords

  • Synthetic biology
  • Performance materials
  • Molecular engineering
  • Bio-based ingredients
  • Specialty polymers

Where Cambrium is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Cambrium business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. B2B Materials Sales: Revenue generated through direct B2B sales of specialty molecular ingredients and performance materials to enterprise customers in target industries. The company manufactures and supplies novel enzymes, polymers, and peptides to partner companies for integration into their products.
  2. Collaborative Development: Revenue from co-development partnerships with companies seeking custom molecular solutions. Cambrium partners with companies to develop materials that didn't exist until they made them, suggesting custom development and manufacturing agreements.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Cambrium product offering

Product offering

Core offering

Cambrium engineers and manufactures high-performance proteins and specialty molecular ingredients—including enzymes, polymers, and peptides—using a proprietary molecular intelligence platform that combines AI-driven prediction with synthetic biology production. The company sells these bio-based, biodegradable ingredients to enterprise customers in personal care, apparel and footwear, home care, and mobility industries as sustainable alternatives to petrochemical- and animal-derived inputs.

Product overview

Cambrium is a synthetic biology company that develops sustainable performance molecules using AI-powered molecular intelligence. Their platform spans three molecular systems — enzymes, polymers, and peptides — enabling the design and manufacturing of materials for personal care, apparel and footwear, home care, and other industries. The product portfolio includes NovaColl™ (bioidentical anti-aging peptide), RevaBond™ (bond repair), LumaCell™ (cellular longevity), and EvoSance™ (hair rejuvenation) for personal care; Microcellular Foam, Protective Coatings, and Stretch Fibers for apparel and footwear; and custom enzymes for home care applications. All products are designed for biodegradability and sustainable alternatives to petrochemical and animal-derived ingredients.

Differentiator

Problem solved

Functional benefit

Brands

  • NovaColl™: Bioidentical anti-aging peptide for personal care applications
  • RevaBond™
  • LumaCell™
  • EvoSance™
  • Microcellular Foam
  • Protective Coatings
  • Stretch Fibres
  • Washing Detergent

Products and services

  • NovaColl™ Bioidentical anti-aging peptide for personal care applications — a skin-identical vegan collagen alternative that mirrors what the body naturally produces, offering deeper absorption and stronger signaling compared to synthetic chemistry alternatives.
  • RevaBond™ All-natural bond repair ingredient for personal care formulations, designed to restore hair or material bonds.
  • LumaCell™ Active ingredient designed for longevity at the cellular level in personal care applications.
  • EvoSance™ Follicle-first hair rejuvenation technology for personal care applications.
  • Microcellular Foam Performance polymer engineered for apparel and footwear applications — microcellular foam tuned for energy return in footwear midsoles, providing stretch, resilience, and breathability.
  • Protective Coatings Invisible protective coating technology for apparel, footwear, and accessories, providing durability and protection without compromising aesthetics.
  • Stretch Fibres Performance fiber technology engineered for stretch and resilience in textile applications, designed to provide comfort and flexibility.
  • Enzymes and Bio-based Actives Custom enzymes engineered for specific cleaning challenges in home care applications — designed to clean effectively at lower temperatures, biodegrade completely, and work gently on fabrics and surfaces.

Quantifiable outcome

  • Independent studies have shown positive results for NovaColl efficacy

Companies that use Cambrium

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Cambrium technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature11 records

Cambrium partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BrenntagcoreChannel Partner/ Reseller/ Distributor · 10 January 2025Brenntag Beauty and Personal Care partnered with Cambrium to launch skin-identical vegan collagen (NovaColl) in key European markets. Brenntag, as a global chemical distributor, provides Cambrium with access to their extensive personal care customer network across Europe, enabling wide distribution of Cambrium's breakthrough collagen ingredient.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Cambrium competitors and assessment

Company assessment

Direct peers

  • Geltor: Direct competitor developing animal-free proteins and peptides via precision fermentation for personal care and food applications. Geltor and Cambrium both use synthetic biology to produce bioidentical collagen and other proteins as sustainable alternatives to animal-derived ingredients, targeting the same CPG brand customers.
  • Spiber: Direct competitor using brewed protein (fermentation-based) to produce structural protein fibers for apparel and footwear applications. Spiber and Cambrium's apparel & footwear division both target performance material customers seeking bio-based alternatives to petroleum-derived synthetics like spandex and nylon.
  • Bolt Threads: Direct competitor producing lab-grown proteins (including spider silk-inspired fibers and beauty ingredients) via synthetic biology for fashion, beauty, and personal care applications. Bolt Threads and Cambrium both bridge sustainable protein materials from biotech into CPG and apparel end markets.
  • Cradle: Direct competitor applying generative AI and machine learning to protein design, helping partners engineer novel proteins faster. Cradle and Cambrium share the same AI-for-biology platform thesis and target similar enterprise customers in the protein engineering space, though Cradle operates more as a software/partner model.
  • Modern Meadow: Direct competitor using bio-fabrication and synthetic biology to produce sustainable materials, including bio-based leather alternatives and protein-based materials for fashion and automotive applications. Modern Meadow and Cambrium both target materials-intensive industries with fermentation-derived alternatives to animal- and petrochemical-derived inputs.

Emerging players

  • Insempra: Emerging European synthetic biology company producing fermentation-derived specialty ingredients for cosmetics, food, and materials. Insempra overlaps with Cambrium on bio-based personal-care ingredients and shares the European market footprint, though Insempra's ingredient portfolio is more nutrition-oriented.

Broad incumbents

  • Croda International: Global specialty ingredients leader with a deep personal-care and beauty portfolio serving the same CPG customers Cambrium targets via Brenntag. Croda's Personal Care division competes directly with NovaColl and other Cambrium bioactive peptides, while its established regulatory dossiers and global sales force represent the benchmark Cambrium must displace.
  • Evonik Industries: Major specialty chemicals company with significant personal-care, cosmetics, and sustainable materials businesses. Evonik's Care Solutions division and its biolab-produced ingredients (e.g., ceramides, peptides) compete directly with Cambrium's bioactives, while its polymer portfolio overlaps with Cambrium's performance materials work.
  • BASF: World's largest chemical company with a Care Chemicals division serving personal care, home care, and industrial cleaning customers — overlapping with Cambrium's enzymatic home-care actives and personal-care peptides. BASF's massive R&D budget and established CPG relationships represent both a competitive threat and a potential partnership/acquisition counterparty for Cambrium.
  • dsm-firmenich: Global leader in nutrition, health, and beauty ingredients formed by the merger of DSM and Firmenich. The Personal Care & Aroma Ingredients division competes directly with Cambrium's peptide and bioactive portfolio for CPG brand customers, while dsm-firmenich's sustainability positioning overlaps with Cambrium's animal-free value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Cambrium social profiles

Digital presence

Cambrium financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambrium leadership team

Management profile

Number of profiles

Profiles5 records

Cambrium funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambrium M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambrium

What does Cambrium do?

Cambrium engineers and manufactures high-performance proteins and specialty molecular ingredients—including enzymes, polymers, and peptides—using a proprietary molecular intelligence platform that combines AI-driven prediction with synthetic biology production. The company sells these bio-based, biodegradable ingredients to enterprise customers in personal care, apparel and footwear, home care, and mobility industries as sustainable alternatives to petrochemical- and animal-derived inputs.

Is Cambrium a public or private company?

Cambrium is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cambrium founded?

Cambrium was founded in 2020. It employs 11 to 50 people.

Where is Cambrium based?

Cambrium is headquartered in Berlin, Germany, in the Europe region.

How does Cambrium make money?

Two revenue lines are on record. B2B Materials Sales are the primary driver. The others are collaborative Development.

Who are Cambrium's main competitors?

Direct peers on record are Geltor, Spiber, Bolt Threads, Cradle and Modern Meadow. Insempra is listed as an emerging player. Broad incumbents are Croda International, Evonik Industries, BASF and dsm-firmenich.

Does Cambrium have an API?

No public API is recorded for Cambrium.

What industry is Cambrium in?

Cambrium's product category is Specialty Bio-based Ingredients. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of AFAJAHAL, Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins). Its NAICS code is 325414 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyWhy the future of skin longevity belongs to generative bio-platformsGenerative AI is re-engineering skin rejuvenation by designing functional collagen from scratch, overcoming animal-derived and recombinant limitations. Cambrium's AI-driven pipeline achieves a 90% secretion success rate versus 5% with conventional methods. Capital is shifting toward AI-backed discovery, with Debut raising $20 million in August 2025.BiooekonomieMitchell Duffy - Der ProteindesignerMitchell Duffy, CEO of Cambrium, discusses the company's use of artificial intelligence to design novel structural proteins for sustainable materials. The firm has launched its first product, NovaColl, a human-identical collagen produced via yeast fermentation for the cosmetics industry as an alternative to animal-derived sources.StartupSeekerCambrium - Funding: $10M+Cambrium, a Berlin-based startup, has raised over $10 million in funding to support its development of NovaColl™, a micro-molecular collagen produced via precision fermentation. This technology serves as a sustainable alternative to animal-derived collagen for the skincare industry by eliminating animal extraction and improving skin absorption.Amazon Web ServicesCambrium Advances Protein Design and Develops Sustainable Materials 5 Times Faster Using AWSCambrium has accelerated its sustainable material development process by five times and reduced costs by twenty times using AWS infrastructure, including Amazon SageMaker and AWS Batch. The company utilizes AI-driven protein engineering to create alternatives like NovaColl, which generates 95% fewer emissions than traditional materials. This technological shift enables Cambrium to scale protein analysis from small datasets to millions of items within hours.PitchBookCambrium 2025 Company Profile: Valuation, Funding & InvestorsCambrium, a Berlin-based biotechnology company, completed a $9.2 million seed funding round on November 5, 2024. This latest investment brings the company's total funding to $12.8 million since its founding in 2020.YouTubeCambrium: Harnessing AI to unlock the next wave of material innovationGerman biotechnology company Cambrium is utilizing Benchling’s laboratory data platform to streamline its molecular design processes and enhance the application of AI models for developing sustainable materials. This integration allows for centralized data capture and improved visibility into R&D pipelines, facilitating the commercialization of high-performance collagen and other future products.Tracxn2025 Company Profile, Funding, Competitors & FinancialsCambrium is a provider of protein-based biomaterials for skin applications that has raised a total of $11.6M across two funding rounds, with its latest Seed round occurring on November 5, 2024. The company utilizes AI-based technology to produce vegan collagen products for researchers and had Earth Venture Capital as a lead investor in its most recent financing.Merantix-CapitalWhy we invest in AI for materials discoveryMerantix Capital highlights the transformative potential of AI in accelerating materials discovery, citing its portfolio company Cambrium and other startups like CuspAI as key examples of this trend. The article details how AI-driven platforms are significantly reducing development times and costs for novel materials used in sectors such as clean energy, batteries, and carbon capture. It outlines strategic opportunities for founders to enter the market through software platforms, OEM partnerships, or full-stack production models.LuxresearchincAI in Synthetic Biology: Necessary or Nice to Have?Lux Research analyzes the functional necessity of AI in synthetic biology, concluding that while AI is critical for novel molecule discovery and beneficial for strain engineering and lab automation, its role in bioprocess optimization remains optional. The report highlights companies like Cambrium, Cradle Bio, and Pow.Bio as key players leveraging these technologies to accelerate development timelines and improve efficiency. It suggests that AI's indispensability will likely increase over the next few years as synthetic systems become more modular and control systems more anticipatory.BrenntagThe collagen revolution in beautyThe beauty industry is experiencing a surge in demand for collagen-based products, driven by consumer interest in skin-rejuvenating benefits and a shift toward sustainable, vegan alternatives. Companies are responding with new product launches and biotech innovations, such as Cambrium's NovaColl™, to meet these needs. Brenntag is positioning itself to support brands by providing specialty ingredients and formulation guidance for next-generation collagen solutions.